Messner & Smith Theme Value Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-27,495	Closed	-$753K	–	76
2014 Q2	$753K	Buy	27,495 +523	+2%	+$13.9K	1.19%	31
2014 Q1	$711K	Buy	26,972 +6	+0%	+$172	1.07%	33
2013 Q4	$789K	Buy	26,966 +432	+2%	+$13.7K	1.72%	25
2013 Q3	$811K	Sell	26,534 -1,950	-7%	-$65.2K	1.92%	18
2013 Q2	$903K	Buy	+28,484	New	+$936K	2.09%	17

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's GHDX Position: Q3 2014 in Review

Messner & Smith Theme Value Investment Management sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 27,495 shares — an estimated $753K sold.

Messner & Smith Theme Value Investment Management first reported a position in GHDX in Q2 2013 and held it in 5 quarters. The position peaked at $903K in Q2 2013. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

Messner & Smith Theme Value Investment Management reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
Messner & Smith Theme Value Investment Management sold 27,495 Genomic Health, Inc. shares in Q3 2014, an estimated $753K.
Messner & Smith Theme Value Investment Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 5 quarters.
Messner & Smith Theme Value Investment Management's Genomic Health, Inc. position peaked at $903K in Q2 2013.
107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q3 2014, filed 4 Nov 2014.